V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160015207 | 160007529 | 1.72 | 65.8 | null | 2017-07-04 | 2017-07-07 | Cisplatin + Pemetrexed | null | null | CISPLATIN + PEMETREXED | 100010049 |
| 160015208 | 160007530 | 0 | 20.2 | Palliative (P) | 2016-05-21 | 2019-05-22 | MELPHALAN | 02 | N | PACLITAXEL | 100192841 |
| 160015210 | 160007531 | 1.74 | 54.6 | Neo-adjuvant (N) | 2016-12-31 | 2017-01-14 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101297143 |
| 160015211 | 160007532 | 1.62 | 79.2 | Palliative (P) | 2019-06-30 | 2019-07-14 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 100161469 |
| 160015213 | 160007533 | null | 60.75 | Neo-adjuvant (N) | 2016-01-27 | 2016-02-03 | CARBOPLATIN + PACLITAXEL | Y | N | CARBOPLATIN + PACLITAXEL | 101159400 |
| 160015216 | 160007534 | 1.71 | 92.4 | null | 2017-07-24 | 2017-08-10 | Avelumab | N | N | CARBOPLATIN + PACLITAXEL | 100121154 |
| 160015218 | 160007535 | 1.65 | 77.1 | Curative (C) | 2018-07-24 | 2018-07-24 | ICON8 TRIAL | 02 | N | EW EUROEWING 2012 ARM A VIDE | 101141689 |
| 160015219 | 160007536 | 1.8 | 15 | Curative (C) | 2018-04-18 | 2018-04-22 | Cisplatin + Pemetrexed | null | N | CISPLATIN + PEMETREXED | 101165013 |
| 160015220 | 160007537 | null | 49.2 | Curative (C) | 2020-07-11 | 2020-08-11 | STS Non-Rhabdo EpSSG 2005 IVA | 02 | null | STS RHABDOMYOSARCO RMS 2005 IVADOVV | 100471190 |
| 160015221 | 160007538 | 1.75 | 60 | null | 2020-12-08 | 2020-12-14 | Epirubicin (weekly) | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101744259 |
| 160015222 | 160007539 | 1.81 | 70 | Palliative (P) | 2018-04-18 | 2018-05-05 | Cisplatin + Pemetrexed | 2 | N | CISPLATIN + PEMETREXED | 100779889 |
| 160015225 | 160007540 | 1.56 | 65 | Palliative (P) | 2019-10-17 | 2019-10-23 | DOXORUBICIN | 02 | N | TRIAL | 101772913 |
| 160015226 | 160007541 | 1.94 | 91 | Adjuvant (A) | 2018-04-04 | 2018-04-18 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101829245 |
| 160015227 | 160007542 | 1.6 | 59.7 | Neo-adjuvant (N) | 2014-01-31 | 2019-09-04 | PACLITAXEL | 02 | N | DOXORUBICIN | 100290502 |
| 160015228 | 160007543 | 1.57 | 53.4 | Neo-adjuvant (N) | 2018-02-26 | 2018-02-27 | Carboplatin AUC 2 - 5 | N | N | CARBOPLATIN | 101156994 |
| 160015229 | 160007544 | 1.77 | 13.5 | null | 2017-10-30 | 2018-03-02 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 100843687 |
| 160015231 | 160007545 | 1.78 | 98.6 | Palliative (P) | 2017-07-21 | 2017-07-28 | Doxorubicin + Ifosfamide | null | N | TRIAL | 101525217 |
| 160015234 | 160007546 | 1.85 | 83 | Palliative (P) | 2017-06-23 | 2017-07-06 | Dasatinib | 02 | null | TRIAL UNSPECIFIED | 101264370 |
| 160015237 | 160007547 | 1.74 | 0 | Palliative (P) | 2019-03-20 | 2019-04-02 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100276483 |
| 160015238 | 160007548 | 1.04 | 92.2 | Neo-adjuvant (N) | null | 2017-05-01 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 101527365 |
| 160015240 | 160007549 | null | 106 | Palliative (P) | 2017-11-19 | 2017-11-19 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 101552054 |
| 160015241 | 160007550 | 1.85 | 82.6 | Palliative (P) | 2017-10-06 | 2017-10-21 | Doxorubicin + Ifosfamide | 02 | N | DOXORUBICIN + IFOSFAMIDE | 100242289 |
| 160015242 | 160007551 | 1.79 | 70 | Palliative (P) | null | 2017-03-02 | Cisplatin + Pemetrexed | 2 | N | CISPLATIN + PEMETREXED | 101231906 |
| 160015245 | 160007552 | 165 | 87 | Palliative (P) | null | 2019-03-06 | Cisplatin + Pemetrexed | 2 | N | CISPLATIN + PEMETREXED | 100082499 |
| 160015246 | 160007553 | 1.65 | 66.4 | null | 2017-04-09 | 2017-04-10 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100480427 |
| 160015248 | 160007554 | null | null | null | 2018-11-18 | 2018-11-18 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 100183522 |
| 160015254 | 160007555 | 1.73 | 74 | Palliative (P) | 2020-09-10 | 2020-09-11 | CYCLO + DOXORUBICIN + VINCRISTINE | 02 | N | LIPOSOMAL DOXORUBICIN | 101361438 |
| 160015256 | 160007556 | 1.71 | 73.35 | Palliative (P) | 2018-12-18 | 2019-01-11 | Doxorubicin + Olaratumab | 02 | N | PACLITAXEL | 100562158 |
| 160015257 | 160007557 | 1.8 | 50.8 | Palliative (P) | 2020-07-13 | 2020-07-20 | Oxaliplatin + Modified de Gramont | 02 | N | DOXORUBICIN | 101097484 |
| 160015259 | 160007559 | 1.71 | 71.3 | Palliative (P) | 2017-03-17 | 2017-03-19 | ETOP 13-18 BEAT-meso Trial | 02 | null | BORTEZOMIB | 101586760 |
| 160015260 | 160007560 | 1.75 | 90 | Palliative (P) | 2016-12-12 | 2016-12-13 | Vinorelbine (oral) | 02 | N | TRIAL | 101303695 |
| 160015261 | 160007561 | 1.76 | 82.8 | Curative (C) | 2016-03-27 | 2016-03-27 | NB Low/Interm risk guidelines Carbo/Etop | 02 | N | DOXORUBICIN + OLARATUMAB | 101529405 |
| 160015267 | 160007563 | 1.66 | 65.7 | Neo-adjuvant (N) | 2016-04-08 | 2016-04-17 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 100037503 |
| 160015269 | 160007564 | 1.79 | 115 | Neo-adjuvant (N) | 2017-10-13 | 2017-10-19 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | CAV | 100233828 |
| 160015271 | 160007565 | 1.68 | 82 | Palliative (P) | 2019-11-21 | 2019-11-21 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 100157278 |
| 160015272 | 160007566 | 1.48 | 66 | Palliative (P) | 2020-03-19 | 2020-03-20 | Carboplatin + Paclitaxel (3 weekly) | N | N | CARBOPLATIN + PACLITAXEL | 101150154 |
| 160015278 | 160007567 | 1.58 | 65.4 | Palliative (P) | 2017-01-11 | 2017-01-26 | Trial Unspecified | 2 | N | TRIAL UNSPECIFIED | 100252141 |
| 160015280 | 160007568 | 1.79 | null | Adjuvant (A) | 2018-08-24 | 2018-08-27 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100414829 |
| 160015281 | 160007569 | 1.87 | 80.8 | Curative (C) | 2016-05-12 | 2016-06-03 | Ipilimumab | 02 | N | TRABECTEDIN | 101769600 |
| 160015283 | 160007570 | 1.54 | 74.6 | Neo-adjuvant (N) | 2016-12-07 | 2016-12-21 | Cisplatin + Pemetrexed | null | N | TRABECTEDIN | 100680864 |
| 160015284 | 160007571 | null | 59.15 | null | 2019-02-26 | 2019-02-26 | Doxorubicin + Ifosfamide | 02 | null | LIPOSOMAL DOXORUBICIN | 101573679 |
| 160015285 | 160007572 | 1.77 | 64 | Palliative (P) | 2019-07-06 | 2019-07-06 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100374333 |
| 160015290 | 160007573 | 1.74 | 82.8 | Curative (C) | 2017-01-20 | 2017-01-21 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | IPM | 101658935 |
| 160015291 | 160007574 | 1.58 | 105.9 | Curative (C) | 2020-02-04 | 2020-02-04 | Cisplatin + Pemetrexed | 01 | N | CISPLATIN + PEMETREXED | 101660377 |
| 160015293 | 160007575 | 1.82 | 62.4 | Palliative (P) | null | 2017-03-15 | Hydroxycarbamide | N | Y | DOXORUBICIN + IFOSFAMIDE | 101863393 |
| 160015294 | 160007576 | 1.69 | 58 | null | 2016-02-17 | 2016-02-19 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101543480 |
| 160015298 | 160007578 | 1.79 | 45 | Curative (C) | 2019-02-23 | 2019-03-05 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 101260778 |
| 160015301 | 160007579 | 0 | 94 | Palliative (P) | 2019-10-15 | 2019-10-22 | Cisplatin + Pemetrexed | 2 | N | CISPLATIN + PEMETREXED | 100376977 |
| 160015304 | 160007580 | null | 82.6 | Palliative (P) | 2018-07-19 | 2018-07-19 | Doxorubicin 75mg/m2 | 02 | null | DOXORUBICIN | 100008806 |
| 160015305 | 160007581 | 1.74 | 79 | Palliative (P) | 2016-03-14 | 2016-03-31 | Doxorubicin + Olaratumab | 02 | N | NOT MATCHED | 100572495 |